Get the Stockscreener App
637.86
1.99%
-12.98
Pre-market:
637.49
-0.37
-0.06%
Idexx Laboratories Inc stock is traded at $637.86, with a volume of 436.48K.
It is down -1.99% in the last 24 hours and up +23.95% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$650.84
Open:
$650.45
24h Volume:
436.48K
Relative Volume:
0.74
Market Cap:
$51.03B
Revenue:
$4.04B
Net Income/Loss:
$985.66M
P/E Ratio:
53.11
EPS:
12.01
Net Cash Flow:
$774.34M
1W Performance:
-2.19%
1M Performance:
+23.95%
6M Performance:
+42.04%
1Y Performance:
+29.58%
1-Day Range:
$637.08
$652.08
1-Week Range:
$637.08
$665.02
52-Week Range:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
637.86 | 52.07B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
487.54 | 184.66B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.01 | 151.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
118.15 | 33.86B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
192.54 | 32.49B | 15.70B | 1.24B | 2.01B | 6.91 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
National Veterinary Associates Welcomes Brian McKeon to Board of Directors - The Malaysian Reserve
Live Chart Scan Detects Wedge Pattern in IDEXX Laboratories Inc.2025 Buyback Activity & AI Based Trade Execution Alerts - newsyoung.net
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Published on: 2025-08-17 06:07:39 - beatles.ru
Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25% - simplywall.st
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Aardvark Therapeutics, Inc. (AARD) - The Globe and Mail
Why IDEXX Laboratories Inc. stock attracts strong analyst attentionJuly 2025 WrapUp & Daily Risk Controlled Trade Plans - thegnnews.com
How IDEXX Laboratories Inc. stock performs during market volatilityJuly 2025 Retail & Verified Momentum Stock Ideas - sundaytimes.kr
IDEXX Laboratories: A Powerhouse in Veterinary Diagnostics with Strong Q2 2025 Outperformance and Strategic Innovation - AInvest
IDEXX Laboratories 2025 Investor Day: Jay Mazelsky Presentation - AInvest
Transcript : IDEXX Laboratories, Inc.Analyst/Investor Day - MarketScreener
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $745 to $785 - 富途牛牛
IDEXX Laboratories: Morgan Stanley raises PT to $765, maintains Overweight rating. - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $263,814, According to a Recent SEC Filing - MarketScreener
Is IDEXX Laboratories Inc. forming a double bottomJuly 2025 Patterns & Real-Time Stock Movement Alerts - thegnnews.com
Insider Sell: Michael Erickson Sells Shares of IDEXX Laboratories Inc (IDXX) - GuruFocus
IDEXX Laboratories Executive Vice President Erickson Sells Shares on August 12, 2025. - AInvest
IDEXX Laboratories : Investor Day 2025 presentation - MarketScreener
There's Reason For Concern Over IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Massive 26% Price Jump - 富途牛牛
IDEXX Laboratories Executive Vice President Hunts Nimrata sells 1200 shares. - AInvest
Idexx Labs executive Hunt sells $787k in shares - Investing.com
Idexx Labs executive Hunt sells $787k in shares By Investing.com - Investing.com Canada
Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results - Yahoo Finance
IDEXX Laboratories EVP buys, sells shares in single day. - AInvest
IDEXX Laboratories' 15min chart shows MACD, KDJ death crosses. - AInvest
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today - Yahoo Finance
A Closer Look at IDEXX Laboratories's Options Market Dynamics - Benzinga
IDEXX Laboratories' 15min chart: RSI Overbought, KDJ Death Cross triggered. - AInvest
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $700 From $510, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories: Piper Sandler Raises PT to $700 from $510 - AInvest
Idexx Laboratories Inc Insider Sold Shares Worth $5,279,893, According to a Recent SEC Filing - MarketScreener
Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - 富途牛牛
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Short Interest Drops in IDEXX Laboratories Inc. After RallyLow Capital High Return Stock Plans Reviewed - beatles.ru
IDEXX Executives Make Major Stock Trades on August 6 - AInvest
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$5.28 Million in Common Stock - 富途牛牛
IDEXX Labs Volume Plummets 28% as Veterinary Diagnostics Stock Slides to 256th in U.S. Trading Activity Rankings - AInvest
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $675.00 at JPMorgan Chase & Co. - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
IDEXX’s Healthy Streak Outpaces The Pack In Animal Care - Finimize
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - MSN
IDEXX Laboratories shares rise 3.10% intraday after Rothschild & Co Redburn raised price target to $670. - AInvest
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
IDEXX Laboratories Q2 2025 Earnings Call: Strong Revenue and EPS Growth Amid Challenges - AInvest
BTIG Boosts Idexx Laboratories Price Target to $785 Amid Strong Q2 Earnings - AInvest
Leerink Partners Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $745 - 富途牛牛
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript - Insider Monkey
Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year - inkl
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):